{"id": "1009874", "images": ["1009874-0.png"], "objects": {"ecg": ["1009874"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1013884", "images": ["1013884-0.png"], "objects": {"ecg": ["1013884"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1023925", "images": ["1023925-0.png"], "objects": {"ecg": ["1023925"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1036640", "images": ["1036640-0.png"], "objects": {"ecg": ["1036640"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1041375", "images": ["1041375-0.png"], "objects": {"ecg": ["1041375"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1053511", "images": ["1053511-0.png"], "objects": {"ecg": ["1053511"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1054733", "images": ["1054733-0.png"], "objects": {"ecg": ["1054733"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1058085", "images": ["1058085-0.png"], "objects": {"ecg": ["1058085"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1058605", "images": ["1058605-0.png"], "objects": {"ecg": ["1058605"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1061898", "images": ["1061898-0.png"], "objects": {"ecg": ["1061898"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1063368", "images": ["1063368-0.png"], "objects": {"ecg": ["1063368"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1073253", "images": ["1073253-0.png"], "objects": {"ecg": ["1073253"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1074787", "images": ["1074787-0.png"], "objects": {"ecg": ["1074787"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1080968", "images": ["1080968-0.png"], "objects": {"ecg": ["1080968"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1081032", "images": ["1081032-0.png"], "objects": {"ecg": ["1081032"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1081338", "images": ["1081338-0.png"], "objects": {"ecg": ["1081338"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1084994", "images": ["1084994-0.png"], "objects": {"ecg": ["1084994"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1085203", "images": ["1085203-0.png"], "objects": {"ecg": ["1085203"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1087704", "images": ["1087704-0.png"], "objects": {"ecg": ["1087704"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1088175", "images": ["1088175-0.png"], "objects": {"ecg": ["1088175"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1088261", "images": ["1088261-0.png"], "objects": {"ecg": ["1088261"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1088796", "images": ["1088796-0.png"], "objects": {"ecg": ["1088796"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1092237", "images": ["1092237-0.png"], "objects": {"ecg": ["1092237"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1093224", "images": ["1093224-0.png"], "objects": {"ecg": ["1093224"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1096625", "images": ["1096625-0.png"], "objects": {"ecg": ["1096625"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1097714", "images": ["1097714-0.png"], "objects": {"ecg": ["1097714"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1098314", "images": ["1098314-0.png"], "objects": {"ecg": ["1098314"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1099262", "images": ["1099262-0.png"], "objects": {"ecg": ["1099262"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1102607", "images": ["1102607-0.png"], "objects": {"ecg": ["1102607"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1103983", "images": ["1103983-0.png"], "objects": {"ecg": ["1103983"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1106149", "images": ["1106149-0.png"], "objects": {"ecg": ["1106149"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1112604", "images": ["1112604-0.png"], "objects": {"ecg": ["1112604"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1117553", "images": ["1117553-0.png"], "objects": {"ecg": ["1117553"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1118251", "images": ["1118251-0.png"], "objects": {"ecg": ["1118251"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1121137", "images": ["1121137-0.png"], "objects": {"ecg": ["1121137"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1122903", "images": ["1122903-0.png"], "objects": {"ecg": ["1122903"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1124825", "images": ["1124825-0.png"], "objects": {"ecg": ["1124825"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1124826", "images": ["1124826-0.png"], "objects": {"ecg": ["1124826"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1128835", "images": ["1128835-0.png"], "objects": {"ecg": ["1128835"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1134284", "images": ["1134284-0.png"], "objects": {"ecg": ["1134284"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1135434", "images": ["1135434-0.png"], "objects": {"ecg": ["1135434"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1138153", "images": ["1138153-0.png"], "objects": {"ecg": ["1138153"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1141322", "images": ["1141322-0.png"], "objects": {"ecg": ["1141322"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1142915", "images": ["1142915-0.png"], "objects": {"ecg": ["1142915"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1145203", "images": ["1145203-0.png"], "objects": {"ecg": ["1145203"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1146063", "images": ["1146063-0.png"], "objects": {"ecg": ["1146063"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1147684", "images": ["1147684-0.png"], "objects": {"ecg": ["1147684"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1148718", "images": ["1148718-0.png"], "objects": {"ecg": ["1148718"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1152054", "images": ["1152054-0.png"], "objects": {"ecg": ["1152054"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1157038", "images": ["1157038-0.png"], "objects": {"ecg": ["1157038"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1160261", "images": ["1160261-0.png"], "objects": {"ecg": ["1160261"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1165447", "images": ["1165447-0.png"], "objects": {"ecg": ["1165447"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1165448", "images": ["1165448-0.png"], "objects": {"ecg": ["1165448"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1169405", "images": ["1169405-0.png"], "objects": {"ecg": ["1169405"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1172602", "images": ["1172602-0.png"], "objects": {"ecg": ["1172602"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1176675", "images": ["1176675-0.png"], "objects": {"ecg": ["1176675"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1177018", "images": ["1177018-0.png"], "objects": {"ecg": ["1177018"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1180702", "images": ["1180702-0.png"], "objects": {"ecg": ["1180702"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1183349", "images": ["1183349-0.png"], "objects": {"ecg": ["1183349"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1184742", "images": ["1184742-0.png"], "objects": {"ecg": ["1184742"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1187599", "images": ["1187599-0.png"], "objects": {"ecg": ["1187599"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1188747", "images": ["1188747-0.png"], "objects": {"ecg": ["1188747"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1190805", "images": ["1190805-0.png"], "objects": {"ecg": ["1190805"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1191551", "images": ["1191551-0.png"], "objects": {"ecg": ["1191551"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1191595", "images": ["1191595-0.png"], "objects": {"ecg": ["1191595"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1192135", "images": ["1192135-0.png"], "objects": {"ecg": ["1192135"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1192146", "images": ["1192146-0.png"], "objects": {"ecg": ["1192146"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1192654", "images": ["1192654-0.png"], "objects": {"ecg": ["1192654"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1197538", "images": ["1197538-0.png"], "objects": {"ecg": ["1197538"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1199480", "images": ["1199480-0.png"], "objects": {"ecg": ["1199480"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1199517", "images": ["1199517-0.png"], "objects": {"ecg": ["1199517"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1199593", "images": ["1199593-0.png"], "objects": {"ecg": ["1199593"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1202306", "images": ["1202306-0.png"], "objects": {"ecg": ["1202306"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1207769", "images": ["1207769-0.png"], "objects": {"ecg": ["1207769"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1207947", "images": ["1207947-0.png"], "objects": {"ecg": ["1207947"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1214441", "images": ["1214441-0.png"], "objects": {"ecg": ["1214441"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1220716", "images": ["1220716-0.png"], "objects": {"ecg": ["1220716"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1221590", "images": ["1221590-0.png"], "objects": {"ecg": ["1221590"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1223519", "images": ["1223519-0.png"], "objects": {"ecg": ["1223519"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1224102", "images": ["1224102-0.png"], "objects": {"ecg": ["1224102"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1228746", "images": ["1228746-0.png"], "objects": {"ecg": ["1228746"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1230482", "images": ["1230482-0.png"], "objects": {"ecg": ["1230482"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1231339", "images": ["1231339-0.png"], "objects": {"ecg": ["1231339"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1235674", "images": ["1235674-0.png"], "objects": {"ecg": ["1235674"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1236012", "images": ["1236012-0.png"], "objects": {"ecg": ["1236012"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1237748", "images": ["1237748-0.png"], "objects": {"ecg": ["1237748"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1238446", "images": ["1238446-0.png"], "objects": {"ecg": ["1238446"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1238671", "images": ["1238671-0.png"], "objects": {"ecg": ["1238671"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1242678", "images": ["1242678-0.png"], "objects": {"ecg": ["1242678"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1244867", "images": ["1244867-0.png"], "objects": {"ecg": ["1244867"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1248576", "images": ["1248576-0.png"], "objects": {"ecg": ["1248576"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1248611", "images": ["1248611-0.png"], "objects": {"ecg": ["1248611"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1252288", "images": ["1252288-0.png"], "objects": {"ecg": ["1252288"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1254062", "images": ["1254062-0.png"], "objects": {"ecg": ["1254062"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1254171", "images": ["1254171-0.png"], "objects": {"ecg": ["1254171"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1254267", "images": ["1254267-0.png"], "objects": {"ecg": ["1254267"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1259391", "images": ["1259391-0.png"], "objects": {"ecg": ["1259391"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1263008", "images": ["1263008-0.png"], "objects": {"ecg": ["1263008"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1270798", "images": ["1270798-0.png"], "objects": {"ecg": ["1270798"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1272319", "images": ["1272319-0.png"], "objects": {"ecg": ["1272319"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1272821", "images": ["1272821-0.png"], "objects": {"ecg": ["1272821"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1274776", "images": ["1274776-0.png"], "objects": {"ecg": ["1274776"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1275329", "images": ["1275329-0.png"], "objects": {"ecg": ["1275329"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1277374", "images": ["1277374-0.png"], "objects": {"ecg": ["1277374"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1278746", "images": ["1278746-0.png"], "objects": {"ecg": ["1278746"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1280588", "images": ["1280588-0.png"], "objects": {"ecg": ["1280588"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1281380", "images": ["1281380-0.png"], "objects": {"ecg": ["1281380"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1284182", "images": ["1284182-0.png"], "objects": {"ecg": ["1284182"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1285404", "images": ["1285404-0.png"], "objects": {"ecg": ["1285404"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1286512", "images": ["1286512-0.png"], "objects": {"ecg": ["1286512"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1290629", "images": ["1290629-0.png"], "objects": {"ecg": ["1290629"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1290807", "images": ["1290807-0.png"], "objects": {"ecg": ["1290807"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1294540", "images": ["1294540-0.png"], "objects": {"ecg": ["1294540"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1297151", "images": ["1297151-0.png"], "objects": {"ecg": ["1297151"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1297765", "images": ["1297765-0.png"], "objects": {"ecg": ["1297765"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1297767", "images": ["1297767-0.png"], "objects": {"ecg": ["1297767"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1298469", "images": ["1298469-0.png"], "objects": {"ecg": ["1298469"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1303729", "images": ["1303729-0.png"], "objects": {"ecg": ["1303729"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1305051", "images": ["1305051-0.png"], "objects": {"ecg": ["1305051"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1307673", "images": ["1307673-0.png"], "objects": {"ecg": ["1307673"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1307716", "images": ["1307716-0.png"], "objects": {"ecg": ["1307716"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1309300", "images": ["1309300-0.png"], "objects": {"ecg": ["1309300"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1310052", "images": ["1310052-0.png"], "objects": {"ecg": ["1310052"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1312303", "images": ["1312303-0.png"], "objects": {"ecg": ["1312303"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1313974", "images": ["1313974-0.png"], "objects": {"ecg": ["1313974"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1316784", "images": ["1316784-0.png"], "objects": {"ecg": ["1316784"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1318568", "images": ["1318568-0.png"], "objects": {"ecg": ["1318568"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1326991", "images": ["1326991-0.png"], "objects": {"ecg": ["1326991"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1327775", "images": ["1327775-0.png"], "objects": {"ecg": ["1327775"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1327784", "images": ["1327784-0.png"], "objects": {"ecg": ["1327784"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1332388", "images": ["1332388-0.png"], "objects": {"ecg": ["1332388"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1336243", "images": ["1336243-0.png"], "objects": {"ecg": ["1336243"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1337461", "images": ["1337461-0.png"], "objects": {"ecg": ["1337461"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1338772", "images": ["1338772-0.png"], "objects": {"ecg": ["1338772"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1338780", "images": ["1338780-0.png"], "objects": {"ecg": ["1338780"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1342979", "images": ["1342979-0.png"], "objects": {"ecg": ["1342979"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1344639", "images": ["1344639-0.png"], "objects": {"ecg": ["1344639"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1346727", "images": ["1346727-0.png"], "objects": {"ecg": ["1346727"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1350930", "images": ["1350930-0.png"], "objects": {"ecg": ["1350930"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1357325", "images": ["1357325-0.png"], "objects": {"ecg": ["1357325"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1358245", "images": ["1358245-0.png"], "objects": {"ecg": ["1358245"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1360656", "images": ["1360656-0.png"], "objects": {"ecg": ["1360656"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1366050", "images": ["1366050-0.png"], "objects": {"ecg": ["1366050"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1366637", "images": ["1366637-0.png"], "objects": {"ecg": ["1366637"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1370418", "images": ["1370418-0.png"], "objects": {"ecg": ["1370418"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1370819", "images": ["1370819-0.png"], "objects": {"ecg": ["1370819"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1371132", "images": ["1371132-0.png"], "objects": {"ecg": ["1371132"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1371554", "images": ["1371554-0.png"], "objects": {"ecg": ["1371554"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1372180", "images": ["1372180-0.png"], "objects": {"ecg": ["1372180"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1372181", "images": ["1372181-0.png"], "objects": {"ecg": ["1372181"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1381534", "images": ["1381534-0.png"], "objects": {"ecg": ["1381534"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1382112", "images": ["1382112-0.png"], "objects": {"ecg": ["1382112"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1383335", "images": ["1383335-0.png"], "objects": {"ecg": ["1383335"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1385747", "images": ["1385747-0.png"], "objects": {"ecg": ["1385747"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1386698", "images": ["1386698-0.png"], "objects": {"ecg": ["1386698"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1390489", "images": ["1390489-0.png"], "objects": {"ecg": ["1390489"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1403173", "images": ["1403173-0.png"], "objects": {"ecg": ["1403173"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1404688", "images": ["1404688-0.png"], "objects": {"ecg": ["1404688"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1407660", "images": ["1407660-0.png"], "objects": {"ecg": ["1407660"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1408290", "images": ["1408290-0.png"], "objects": {"ecg": ["1408290"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1414022", "images": ["1414022-0.png"], "objects": {"ecg": ["1414022"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1414967", "images": ["1414967-0.png"], "objects": {"ecg": ["1414967"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1416483", "images": ["1416483-0.png"], "objects": {"ecg": ["1416483"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1417008", "images": ["1417008-0.png"], "objects": {"ecg": ["1417008"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1418000", "images": ["1418000-0.png"], "objects": {"ecg": ["1418000"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1419825", "images": ["1419825-0.png"], "objects": {"ecg": ["1419825"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1421261", "images": ["1421261-0.png"], "objects": {"ecg": ["1421261"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1421316", "images": ["1421316-0.png"], "objects": {"ecg": ["1421316"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1422523", "images": ["1422523-0.png"], "objects": {"ecg": ["1422523"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1422770", "images": ["1422770-0.png"], "objects": {"ecg": ["1422770"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1423789", "images": ["1423789-0.png"], "objects": {"ecg": ["1423789"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1424148", "images": ["1424148-0.png"], "objects": {"ecg": ["1424148"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1425960", "images": ["1425960-0.png"], "objects": {"ecg": ["1425960"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "1426919", "images": ["1426919-0.png"], "objects": {"ecg": ["1426919"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "188981", "images": ["188981-0.png"], "objects": {"ecg": ["188981"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "2187085", "images": ["2187085-0.png"], "objects": {"ecg": ["2187085"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "251972", "images": ["251972-0.png"], "objects": {"ecg": ["251972"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "2635972", "images": ["2635972-0.png"], "objects": {"ecg": ["2635972"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "265715", "images": ["265715-0.png"], "objects": {"ecg": ["265715"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "267628", "images": ["267628-0.png"], "objects": {"ecg": ["267628"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "267630", "images": ["267630-0.png"], "objects": {"ecg": ["267630"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "286830", "images": ["286830-0.png"], "objects": {"ecg": ["286830"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "287355", "images": ["287355-0.png"], "objects": {"ecg": ["287355"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "292220", "images": ["292220-0.png"], "objects": {"ecg": ["292220"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "292666", "images": ["292666-0.png"], "objects": {"ecg": ["292666"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3003692", "images": ["3003692-0.png"], "objects": {"ecg": ["3003692"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3004284", "images": ["3004284-0.png"], "objects": {"ecg": ["3004284"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3006598", "images": ["3006598-0.png"], "objects": {"ecg": ["3006598"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3007664", "images": ["3007664-0.png"], "objects": {"ecg": ["3007664"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3009538", "images": ["3009538-0.png"], "objects": {"ecg": ["3009538"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3009950", "images": ["3009950-0.png"], "objects": {"ecg": ["3009950"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3015438", "images": ["3015438-0.png"], "objects": {"ecg": ["3015438"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3015440", "images": ["3015440-0.png"], "objects": {"ecg": ["3015440"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3015449", "images": ["3015449-0.png"], "objects": {"ecg": ["3015449"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3016396", "images": ["3016396-0.png"], "objects": {"ecg": ["3016396"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3016401", "images": ["3016401-0.png"], "objects": {"ecg": ["3016401"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3028930", "images": ["3028930-0.png"], "objects": {"ecg": ["3028930"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3030937", "images": ["3030937-0.png"], "objects": {"ecg": ["3030937"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3035210", "images": ["3035210-0.png"], "objects": {"ecg": ["3035210"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3037390", "images": ["3037390-0.png"], "objects": {"ecg": ["3037390"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3037617", "images": ["3037617-0.png"], "objects": {"ecg": ["3037617"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "304141", "images": ["304141-0.png"], "objects": {"ecg": ["304141"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3043155", "images": ["3043155-0.png"], "objects": {"ecg": ["3043155"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3044775", "images": ["3044775-0.png"], "objects": {"ecg": ["3044775"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3045053", "images": ["3045053-0.png"], "objects": {"ecg": ["3045053"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3045059", "images": ["3045059-0.png"], "objects": {"ecg": ["3045059"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3045751", "images": ["3045751-0.png"], "objects": {"ecg": ["3045751"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3058024", "images": ["3058024-0.png"], "objects": {"ecg": ["3058024"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3058134", "images": ["3058134-0.png"], "objects": {"ecg": ["3058134"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3062045", "images": ["3062045-0.png"], "objects": {"ecg": ["3062045"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3064724", "images": ["3064724-0.png"], "objects": {"ecg": ["3064724"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3065295", "images": ["3065295-0.png"], "objects": {"ecg": ["3065295"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3067191", "images": ["3067191-0.png"], "objects": {"ecg": ["3067191"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3067196", "images": ["3067196-0.png"], "objects": {"ecg": ["3067196"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3071151", "images": ["3071151-0.png"], "objects": {"ecg": ["3071151"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3072833", "images": ["3072833-0.png"], "objects": {"ecg": ["3072833"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3072836", "images": ["3072836-0.png"], "objects": {"ecg": ["3072836"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3073346", "images": ["3073346-0.png"], "objects": {"ecg": ["3073346"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3074751", "images": ["3074751-0.png"], "objects": {"ecg": ["3074751"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3075260", "images": ["3075260-0.png"], "objects": {"ecg": ["3075260"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3080118", "images": ["3080118-0.png"], "objects": {"ecg": ["3080118"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3080186", "images": ["3080186-0.png"], "objects": {"ecg": ["3080186"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3092472", "images": ["3092472-0.png"], "objects": {"ecg": ["3092472"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3093924", "images": ["3093924-0.png"], "objects": {"ecg": ["3093924"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3094047", "images": ["3094047-0.png"], "objects": {"ecg": ["3094047"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3094049", "images": ["3094049-0.png"], "objects": {"ecg": ["3094049"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3095195", "images": ["3095195-0.png"], "objects": {"ecg": ["3095195"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3095200", "images": ["3095200-0.png"], "objects": {"ecg": ["3095200"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3096254", "images": ["3096254-0.png"], "objects": {"ecg": ["3096254"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3099875", "images": ["3099875-0.png"], "objects": {"ecg": ["3099875"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3101011", "images": ["3101011-0.png"], "objects": {"ecg": ["3101011"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3110550", "images": ["3110550-0.png"], "objects": {"ecg": ["3110550"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3113249", "images": ["3113249-0.png"], "objects": {"ecg": ["3113249"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3114582", "images": ["3114582-0.png"], "objects": {"ecg": ["3114582"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3118448", "images": ["3118448-0.png"], "objects": {"ecg": ["3118448"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3128412", "images": ["3128412-0.png"], "objects": {"ecg": ["3128412"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3128947", "images": ["3128947-0.png"], "objects": {"ecg": ["3128947"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3128957", "images": ["3128957-0.png"], "objects": {"ecg": ["3128957"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3133602", "images": ["3133602-0.png"], "objects": {"ecg": ["3133602"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3136075", "images": ["3136075-0.png"], "objects": {"ecg": ["3136075"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3138453", "images": ["3138453-0.png"], "objects": {"ecg": ["3138453"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "3139196", "images": ["3139196-0.png"], "objects": {"ecg": ["3139196"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "314397", "images": ["314397-0.png"], "objects": {"ecg": ["314397"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "316872", "images": ["316872-0.png"], "objects": {"ecg": ["316872"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "317547", "images": ["317547-0.png"], "objects": {"ecg": ["317547"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "319150", "images": ["319150-0.png"], "objects": {"ecg": ["319150"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "319221", "images": ["319221-0.png"], "objects": {"ecg": ["319221"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "325231", "images": ["325231-0.png"], "objects": {"ecg": ["325231"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "325966", "images": ["325966-0.png"], "objects": {"ecg": ["325966"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "329034", "images": ["329034-0.png"], "objects": {"ecg": ["329034"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "329533", "images": ["329533-0.png"], "objects": {"ecg": ["329533"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "395553", "images": ["395553-0.png"], "objects": {"ecg": ["395553"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "405298", "images": ["405298-0.png"], "objects": {"ecg": ["405298"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "406008", "images": ["406008-0.png"], "objects": {"ecg": ["406008"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "413267", "images": ["413267-0.png"], "objects": {"ecg": ["413267"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "419510", "images": ["419510-0.png"], "objects": {"ecg": ["419510"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "419960", "images": ["419960-0.png"], "objects": {"ecg": ["419960"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "428031", "images": ["428031-0.png"], "objects": {"ecg": ["428031"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "434996", "images": ["434996-0.png"], "objects": {"ecg": ["434996"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "438721", "images": ["438721-0.png"], "objects": {"ecg": ["438721"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "445953", "images": ["445953-0.png"], "objects": {"ecg": ["445953"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "450733", "images": ["450733-0.png"], "objects": {"ecg": ["450733"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "460919", "images": ["460919-0.png"], "objects": {"ecg": ["460919"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "461866", "images": ["461866-0.png"], "objects": {"ecg": ["461866"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "466796", "images": ["466796-0.png"], "objects": {"ecg": ["466796"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "471727", "images": ["471727-0.png"], "objects": {"ecg": ["471727"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "478457", "images": ["478457-0.png"], "objects": {"ecg": ["478457"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "482516", "images": ["482516-0.png"], "objects": {"ecg": ["482516"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "482868", "images": ["482868-0.png"], "objects": {"ecg": ["482868"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "487609", "images": ["487609-0.png"], "objects": {"ecg": ["487609"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "489539", "images": ["489539-0.png"], "objects": {"ecg": ["489539"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "505351", "images": ["505351-0.png"], "objects": {"ecg": ["505351"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "506408", "images": ["506408-0.png"], "objects": {"ecg": ["506408"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "509648", "images": ["509648-0.png"], "objects": {"ecg": ["509648"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "516092", "images": ["516092-0.png"], "objects": {"ecg": ["516092"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "519139", "images": ["519139-0.png"], "objects": {"ecg": ["519139"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "519687", "images": ["519687-0.png"], "objects": {"ecg": ["519687"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "532816", "images": ["532816-0.png"], "objects": {"ecg": ["532816"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "538053", "images": ["538053-0.png"], "objects": {"ecg": ["538053"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "540736", "images": ["540736-0.png"], "objects": {"ecg": ["540736"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "548140", "images": ["548140-0.png"], "objects": {"ecg": ["548140"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "548865", "images": ["548865-0.png"], "objects": {"ecg": ["548865"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "558967", "images": ["558967-0.png"], "objects": {"ecg": ["558967"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "571723", "images": ["571723-0.png"], "objects": {"ecg": ["571723"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "577838", "images": ["577838-0.png"], "objects": {"ecg": ["577838"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "580720", "images": ["580720-0.png"], "objects": {"ecg": ["580720"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "581912", "images": ["581912-0.png"], "objects": {"ecg": ["581912"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "592768", "images": ["592768-0.png"], "objects": {"ecg": ["592768"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "596382", "images": ["596382-0.png"], "objects": {"ecg": ["596382"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "597251", "images": ["597251-0.png"], "objects": {"ecg": ["597251"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "613119", "images": ["613119-0.png"], "objects": {"ecg": ["613119"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "614578", "images": ["614578-0.png"], "objects": {"ecg": ["614578"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "614707", "images": ["614707-0.png"], "objects": {"ecg": ["614707"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "622530", "images": ["622530-0.png"], "objects": {"ecg": ["622530"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "624511", "images": ["624511-0.png"], "objects": {"ecg": ["624511"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "625190", "images": ["625190-0.png"], "objects": {"ecg": ["625190"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "641455", "images": ["641455-0.png"], "objects": {"ecg": ["641455"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "643139", "images": ["643139-0.png"], "objects": {"ecg": ["643139"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "801261", "images": ["801261-0.png"], "objects": {"ecg": ["801261"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "806949", "images": ["806949-0.png"], "objects": {"ecg": ["806949"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "807363", "images": ["807363-0.png"], "objects": {"ecg": ["807363"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "812209", "images": ["812209-0.png"], "objects": {"ecg": ["812209"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "812404", "images": ["812404-0.png"], "objects": {"ecg": ["812404"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "814286", "images": ["814286-0.png"], "objects": {"ecg": ["814286"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "816929", "images": ["816929-0.png"], "objects": {"ecg": ["816929"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "819710", "images": ["819710-0.png"], "objects": {"ecg": ["819710"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "821478", "images": ["821478-0.png"], "objects": {"ecg": ["821478"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "822108", "images": ["822108-0.png"], "objects": {"ecg": ["822108"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "822756", "images": ["822756-0.png"], "objects": {"ecg": ["822756"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "829768", "images": ["829768-0.png"], "objects": {"ecg": ["829768"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "830179", "images": ["830179-0.png"], "objects": {"ecg": ["830179"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "841212", "images": ["841212-0.png"], "objects": {"ecg": ["841212"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "841869", "images": ["841869-0.png"], "objects": {"ecg": ["841869"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "844915", "images": ["844915-0.png"], "objects": {"ecg": ["844915"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "849168", "images": ["849168-0.png"], "objects": {"ecg": ["849168"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "852786", "images": ["852786-0.png"], "objects": {"ecg": ["852786"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "855592", "images": ["855592-0.png"], "objects": {"ecg": ["855592"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "865998", "images": ["865998-0.png"], "objects": {"ecg": ["865998"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "866721", "images": ["866721-0.png"], "objects": {"ecg": ["866721"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "873255", "images": ["873255-0.png"], "objects": {"ecg": ["873255"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "878765", "images": ["878765-0.png"], "objects": {"ecg": ["878765"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "887465", "images": ["887465-0.png"], "objects": {"ecg": ["887465"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "891754", "images": ["891754-0.png"], "objects": {"ecg": ["891754"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "894725", "images": ["894725-0.png"], "objects": {"ecg": ["894725"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "898726", "images": ["898726-0.png"], "objects": {"ecg": ["898726"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "903442", "images": ["903442-0.png"], "objects": {"ecg": ["903442"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "903802", "images": ["903802-0.png"], "objects": {"ecg": ["903802"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "907736", "images": ["907736-0.png"], "objects": {"ecg": ["907736"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "913169", "images": ["913169-0.png"], "objects": {"ecg": ["913169"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "918062", "images": ["918062-0.png"], "objects": {"ecg": ["918062"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "920037", "images": ["920037-0.png"], "objects": {"ecg": ["920037"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "921230", "images": ["921230-0.png"], "objects": {"ecg": ["921230"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "930107", "images": ["930107-0.png"], "objects": {"ecg": ["930107"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "935156", "images": ["935156-0.png"], "objects": {"ecg": ["935156"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "938838", "images": ["938838-0.png"], "objects": {"ecg": ["938838"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "939546", "images": ["939546-0.png"], "objects": {"ecg": ["939546"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "945345", "images": ["945345-0.png"], "objects": {"ecg": ["945345"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "952177", "images": ["952177-0.png"], "objects": {"ecg": ["952177"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "952641", "images": ["952641-0.png"], "objects": {"ecg": ["952641"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "953976", "images": ["953976-0.png"], "objects": {"ecg": ["953976"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "958460", "images": ["958460-0.png"], "objects": {"ecg": ["958460"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "958703", "images": ["958703-0.png"], "objects": {"ecg": ["958703"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "959843", "images": ["959843-0.png"], "objects": {"ecg": ["959843"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "960432", "images": ["960432-0.png"], "objects": {"ecg": ["960432"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "962566", "images": ["962566-0.png"], "objects": {"ecg": ["962566"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "964469", "images": ["964469-0.png"], "objects": {"ecg": ["964469"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "965217", "images": ["965217-0.png"], "objects": {"ecg": ["965217"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "967547", "images": ["967547-0.png"], "objects": {"ecg": ["967547"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "968556", "images": ["968556-0.png"], "objects": {"ecg": ["968556"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "969321", "images": ["969321-0.png"], "objects": {"ecg": ["969321"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "970649", "images": ["970649-0.png"], "objects": {"ecg": ["970649"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "972048", "images": ["972048-0.png"], "objects": {"ecg": ["972048"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "972330", "images": ["972330-0.png"], "objects": {"ecg": ["972330"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "972781", "images": ["972781-0.png"], "objects": {"ecg": ["972781"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "980284", "images": ["980284-0.png"], "objects": {"ecg": ["980284"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "982732", "images": ["982732-0.png"], "objects": {"ecg": ["982732"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "985814", "images": ["985814-0.png"], "objects": {"ecg": ["985814"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "991528", "images": ["991528-0.png"], "objects": {"ecg": ["991528"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "994065", "images": ["994065-0.png"], "objects": {"ecg": ["994065"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "994217", "images": ["994217-0.png"], "objects": {"ecg": ["994217"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "994515", "images": ["994515-0.png"], "objects": {"ecg": ["994515"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "998036", "images": ["998036-0.png"], "objects": {"ecg": ["998036"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]} {"id": "999474", "images": ["999474-0.png"], "objects": {"ecg": ["999474"]}, "messages": [{"role": "system", "content": "You are a helpful, harmless clinical ECG assistant. Provide concise, evidence-based interpretations.\n\n## Standardized Clinical Protocol\nUse these thresholds to CONFIRM diagnoses, RULE OUT conditions based on normality, and DIFFERENTIATE based on specific patterns.\n\n### PHASE 1: TECHNICAL QA, RATE & RHYTHM\n* Quality Assurance\n - Artifacts: Check baseline stability.\n - Speed: Confirm standard 25 mm/s.\n - Calibration: Confirm standard 10 mm/mV.\n - Lead Reversal: If P, QRS, & T are inverted in Lead I, suspect arm lead reversal (vs. Dextrocardia).\n* Rate\n - Bradycardia: < 60 bpm.\n - Normal: 60–100 bpm.\n - Tachycardia: > 100 bpm.\n* Rhythm Diagnosis\n - Sinus Rhythm: P waves positive in II, III, aVF; negative in aVR.\n - Irregularly Irregular: Atrial Fibrillation (No P waves).\n - Occasionally Irregular: Atrial Flutter or Ectopic beats.\n - Grouped Beating: AV Blocks (Mobitz I).\n* P Wave Morphology\n - Normal: Lead II < 0.12s width & < 2.5mm height.\n - Right Atrial Abnormality (RAA): Peaked P (> 2.5 mm) in Lead II.\n - Left Atrial Abnormality (LAA): Notched P (> 0.12 s) in Lead II OR Deep terminal negative force in V1.\n\n### PHASE 2: AXIS, CONDUCTION & INTERVALS\n* Frontal Plane Axis\n - Normal (-30° to +90°): Lead I (+) AND Lead II (+).\n - Left Axis Deviation (LAD): Lead I (+) AND Lead II (-).\n * Differentiation: If Lead II is equiphasic, axis is -30° (Normal). If negative, True LAD.\n * Causes: LAH (rS in II, III, aVF), LVH, LBBB, Inferior MI.\n - Right Axis Deviation (RAD): Lead I (-) AND Lead aVF (+).\n * Causes: LPH (rS in I, aVL), RVH, Lateral MI.\n* PR Interval\n - Normal: 0.12–0.20 s.\n - Short (< 0.12 s): WPW (Delta wave), Low atrial rhythm, Upper AV junctional rhythm.\n - Prolonged (> 0.20 s): AV Block I, II, or III.\n* QRS Duration\n - Normal: < 0.10 s.\n - Intermediate (0.10–0.12 s): Incomplete BBB.\n - Wide (> 0.12 s): RBBB (rSR' in V1) or LBBB (QS in V1).\n\n### PHASE 3: VOLTAGE, HYPERTROPHY & CHF\n* QRS Voltage & LVH\n - LVH Criteria: SV1 + RV6 > 35 mm OR R in Lead I > 15 mm OR R in aVL > 11 mm.\n - Low Voltage Criteria: Limb leads < 5 mm OR Precordial leads < 10 mm.\n* R Wave Progression\n - Poor Progression (PRWP): R waves do not grow normally V1–V4.\n - Reversed Progression: Dominant R in V1 (RVH/Posterior MI).\n\n### PHASE 4: ISCHEMIA, INFARCTION & MIMICS\n* ST Elevation (STE)\n - Threshold: >= 1 mm (Limb) / >= 2 mm (Precordial) in contiguous leads.\n - STEMI: Convex (\"Sad Face\") STE + Reciprocal depression.\n - Pericarditis: Diffuse Concave (\"Happy Face\") STE + PR depression.\n* Specific Infarction Localization\n - Inferior: II, III, aVF.\n - Lateral: I, aVL, V5, V6.\n - Septal/Anterior: V1–V4.\n - Right Ventricular (RV) MI: STE V1 > V2.\n* Non-STEMI & Ischemia\n - ST Depression: Horizontal/Downsloping (Ischemia).\n - T Wave Inversion: Symmetrical (Ischemia).\n* Q Waves\n - Pathologic: > 0.03 s wide OR > 0.1 mV deep.\n\n### PHASE 5: ELECTROLYTES & QT\n* QT Interval: Normal QTc <= 440 ms.\n* Electrolytes: Hyperkalemia (Tented T), Hypokalemia (Flat T + U waves).\n\n### PHASE 6: BRUGADA PHENOTYPE & RISK STRATIFICATION\n* Dynamic Lead Prioritization\n - Primary Zone: V1, V2, and V3 (Precordial Right leads).\n - Strategy: Perform global scan first; if ST-elevation (STE) is isolated to V1-V3 without reciprocal changes in V5-V6, trigger Brugada Protocol.\n* Brugada Type 1 (Coved Pattern)\n - Morphology: J-point elevation >= 2 mm followed by a concave/down-sloping ST segment.\n - T-wave: Must be inverted/negative in the same leads.\n - Significance: High specificity for Brugada Syndrome; requires immediate clinical correlation.\n* Brugada Type 2 (Saddle-back Pattern)\n - Morphology: J-point elevation >= 2 mm with ST trough >= 1 mm, creating a \"saddle\" appearance.\n - T-wave: Positive or biphasic.\n - Differentiation: Distinguish from RBBB (look for wide S-wave in Lead I/V6) and Early Repolarization (check for diffuse STE).\n* Clinical Context Integration (Metadata)\n - High-Risk Markers: If patterns are present AND sudden_death history is positive, escalate to \"High-Risk Brugada\".\n - Sampling Correction: Prioritize morphological \"slope\" and J-point \"shelf\" over absolute millimetric precision."}, {"role": "user", "content": "Examine the provided ECG image for signs of Brugada Syndrome. Based on the lead characteristics, determine if there is a risk. Output ONLY 'Yes' or 'No' without any analysis or explanation."}, {"role": "assistant", "content": ""}]}